<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">FORMOTEROL FUMARATE</span><br/>(for-mo-ter'ol)<br/><span class="topboxtradename">Foradil Aerolizer<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">beta-adrenergic agonist (sympathomimetic)</span>; <span class="classification">bronchodilator</span><br/><b>Prototype: </b>Albuterol<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>12 mcg inhalation capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Long-acting selective beta<sub>2</sub>-adrenergic receptor agonist. Stimulates production of intracellular cyclic AMP, which causes relaxation of bronchial smooth
         muscle. Also inhibits release of mediators of immediate hypersensitivity (e.g., histamine and leukotrienes) from mast cells
         in the lung.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Acts locally in lung as a bronchodilator; prevents bronchoconstriction that occurs during an asthma attack.</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of asthma, prevention of exercise induced asthma, prevention of bronchospasm in COPD.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Bronchitis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to formoterol; significantly worsening or acutely deteriorating asthma; severe asthmatic attacks; paradoxical
         bronchospasm; pregnancy (category C); lactation. Safety and efficiency in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Cardiovascular disorders (especially coronary insufficiency, cardiac arrhythmias, and hypertension); convulsive disorders;
         thyrotoxicosis; heightened responsiveness to sympathomimetic amines; diabetes mellitus.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Treatment of Asthma, COPD</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">Inhaled</span> <img src="../images/special/greaterorequal.gif"/>5 y, Inhale contents of 1 capsule q12h<br/><br/><span class="indicationtitle">Prevention of Exercise-Induced Asthma</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">Inhaled</span> <img src="../images/special/greaterorequal.gif"/>12 y, Inhale contents of 1 capsule at least 15 min before exercise, do not
               repeat for at least 12 h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral Inhalation</span><br/><ul>
<li>Remove capsule from blister <small>IMMEDIATELY</small> before use.
         </li>
<li>Avoid exposing capsules to moisture.</li>
<li>Give capsules only by the oral inhalation route and only by using the Aerolizer Inhaler<sup>TM</sup>. Review use of the Aerolizer Inhaler in <i>Patient Instructions for Use</i> provided by manufacturer. Do not use a spacer with the Aerolizer.
         </li>
<li>Instruct patient not to swallow capsule and not to exhale into the Aerolizer.</li>
<li>Patients who have been taking the inhaled form, short-acting beta<sub>2</sub>-agonists regularly (e.g., 34 times a day) are usually instructed to use these drugs <small>ONLY</small> for symptomatic relief of acute asthma symptoms. Check with physician.
         </li>
<li>Store capsules in the blister at 20°25° C (86°77° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> <span class="speceff-common">Viral infections,</span> chest infection, chest pain, fatigue. <span class="typehead">CNS:</span> Headache, tremor, dizziness, insomnia. <span class="typehead">GI:</span> Abdominal pain, dyspepsia, nausea. <span class="typehead">Respiratory:</span> Pharyngitis, bronchitis, dyspnea, tonsillitis, dysphonia, <span class="speceff-life">fatal exacerbation of asthma</span>. <span class="typehead">Skin:</span> Rash. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Effects may be antagonized by <span class="classification">non-selective beta blockers</span>; <span class="classification">xanthines</span>, <span class="classification">steroids</span>; <span class="classification">diuretics</span> may potentiate hypokalemia. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed into plasma after oral inhalation. <span class="typehead">Onset:</span> 13 min. <span class="typehead">Peak:</span> 13 h. <span class="typehead">Metabolism:</span> Metabolized by glucuronidation in the liver. <span class="typehead">Elimination:</span> 60% excreted in urine, 33% in feces. <span class="typehead">Half-Life:</span> 10 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor cardiovascular status with periodic ECG, BP, and HR determinations.</li>
<li>Withhold drug and notify physician immediately of S&amp;S of bronchospasm.</li>
<li>Lab tests: Monitor serum potassium and blood glucose periodically.</li>
<li>Monitor diabetics closely for loss of glycemic control.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not take this drug more frequently than every 12 h.</li>
<li>Use a short-acting inhaler if symptoms develop between doses of formoterol.</li>
<li>Seek medical care immediately if a previously effective dosage regimen fails to provide the usual response, or if swelling
            about the face and neck and difficulty breathing develop.
         </li>
<li>Report any of the following immediately to the physician: Rash, hives, palpitations, chest pain, rapid heart rate, tremor
            or nervousness.
         </li>
<li>Note to diabetics: Monitor blood glucose levels carefully since hyperglycemia is a possible adverse reaction.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>